Climb Bio (CLYM) – Analysts’ Recent Ratings Changes
Climb Bio (NASDAQ: CLYM) has recently received a number of price target changes and ratings updates: 9/16/2026 – Climb Bio was upgraded by Mizuho to “strong-buy”. 9/8/2026 – Climb Bio had its price target raised by Oppenheimer Holdings, Inc. from $18.00 to $25.00. They now have an “outperform” rating on the stock. 9/8/2026 – Climb […]
22 Sep 21:26 · The Markets Daily